| Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind … HGM Heijerman, EF McKone, DG Downey, E Van Braeckel, SM Rowe, ... The Lancet 394 (10212), 1940-1948, 2019 | 1047 | 2019 |
| Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel … KF Chung, P Godard, E Adelroth, J Ayres, N Barnes, P Barnes, E Bel, ... European Respiratory Journal 13 (5), 1198-1208, 1999 | 575 | 1999 |
| Low-dose nitric oxide as targeted anti-biofilm adjunctive therapy to treat chronic Pseudomonas aeruginosa infection in cystic fibrosis RP Howlin, K Cathie, L Hall-Stoodley, V Cornelius, C Duignan, RN Allan, ... Molecular Therapy 25 (9), 2104-2116, 2017 | 195 | 2017 |
| Prevention of viral induced asthma attacks using inhaled budesonide. G Connett, W Lenney Archives of disease in childhood 68 (1), 85-87, 1993 | 182 | 1993 |
| Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with … GB Rogers, MP Carroll, DJ Serisier, PM Hockey, G Jones, V Kehagia, ... Journal of clinical microbiology 44 (7), 2601-2604, 2006 | 174 | 2006 |
| Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy EJ Sims, A Clark, J McCormick, G Mehta, G Connett, A Mehta, ... Pediatrics 119 (1), 19-28, 2007 | 165 | 2007 |
| Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches H Lund-Palau, AR Turnbull, A Bush, E Bardin, L Cameron, O Soren, ... Expert review of respiratory medicine 10 (6), 685-697, 2016 | 161 | 2016 |
| Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis WD Smith, E Bardin, L Cameron, CL Edmondson, KV Farrant, I Martin, ... FEMS microbiology letters 364 (14), fnx121, 2017 | 124 | 2017 |
| Use of budesonide in severe asthmatics aged 1-3 years. GJ Connett, C Warde, E Wooler, W Lenney Archives of disease in childhood 69 (3), 351-355, 1993 | 122 | 1993 |
| Airway microbiome and development of bronchopulmonary dysplasia in preterm infants: a systematic review M Pammi, CV Lal, BD Wagner, PM Mourani, P Lohmann, RA Luna, ... The Journal of pediatrics 204, 126-133. e2, 2019 | 110 | 2019 |
| Enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer CW Imrie, G Connett, RI Hall, RM Charnley Alimentary pharmacology & therapeutics 32, 1-25, 2010 | 98 | 2010 |
| Prednisolone and salbutamol in the hospital treatment of acute asthma. GJ Connett, C Warde, E Wooler, W Lenney Archives of disease in childhood 70 (3), 170-173, 1994 | 84 | 1994 |
| A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital AL Dewar, A Stewart, JJ Cogswell, GJ Connett Archives of disease in childhood 80 (5), 421-423, 1999 | 82 | 1999 |
| A population-based study of fish allergy in the Philippines, Singapore and Thailand GJ Connett, I Gerez, EA Cabrera-Morales, A Yuenyongviwat, ... International archives of allergy and immunology 159 (4), 384-390, 2012 | 81 | 2012 |
| Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis TWV Daniels, GB Rogers, FA Stressmann, CJ Van Der Gast, KD Bruce, ... Journal of Cystic Fibrosis 12 (1), 22-28, 2013 | 70 | 2013 |
| Molecular microbiological characterization of preterm neonates at risk of bronchopulmonary dysplasia MS Payne, KCW Goss, GJ Connett, T Kollamparambil, JP Legg, ... Pediatric research 67 (4), 412-418, 2010 | 66 | 2010 |
| Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches GB Rogers, TWV Daniels, A Tuck, MP Carroll, GJ Connett, GJP David, ... BMC pulmonary medicine 9, 1-11, 2009 | 65 | 2009 |
| Lumacaftor-ivacaftor in the treatment of cystic fibrosis: design, development and place in therapy GJ Connett Drug Design, Development and Therapy, 2405-2412, 2019 | 61 | 2019 |
| Bronchoscopic appearances of congenital lobar emphysema IJM Doull, GJ Connett, JO Warner Pediatric pulmonology 21 (3), 195-197, 1996 | 59 | 1996 |
| Bronchoalveolar lavage GJ Connett Paediatric Respiratory Reviews 1 (1), 52-56, 2000 | 58 | 2000 |
